Top-down platform for deciphering the human salivary proteome

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue SUPPL. 5, 2012, Pages 27-43

  Castagnola, Massimo ^a,b   Cabras, Tiziana ^c   Iavarone, Federica ^a   Vincenzoni, Federica ^a   Vitali, Alberto ^b   Pisano, Elisabetta ^c   Nemolato, Sonia ^c   Scarano, Emanuele ^d   Fiorita, Antonella ^d   Vento, Giovanni ^e   Tirone, Chiara ^e   Romagnoli, Costantino ^e   Cordaro, Massimo ^a   Paludetti, Gaetano ^d   Faa, Gavino ^c   Messana, Irene ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d Istituto di Clinica Otorinolaringoiatrica   (Italy)

^e Clinica Pediatrica   (Italy)

Author keywords

defensins; thymosins; Cystatins; Histatins; Human; Proline rich proteins; Proteome; Proteomics; S100 proteins; Saliva; Statherin; Top down

Indexed keywords

ACIDIC PROLINE RICH PROTEIN; ALPHA DEFENSIN; BASIC PROLINE RICH PROTEIN; CYSTATIN B; CYSTATIN S; GLYCOSYLATED PROLINE RICH PROTEIN; HISTATIN; LYSOZYME; P B PEPTIDE; PEPTIDE; PROLINE RICH PROTEIN; PROTEOME; SALIVA PROTEIN; SMALL PROLINE RICH PROTEIN 3; STATHERIN; STEFIN A; THYMOSIN BETA10; THYMOSIN BETA4; UNCLASSIFIED DRUG;

AGE; ALTERNATIVE RNA SPLICING; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; NEWBORN CARE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; PREMATURITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; SALIVA ANALYSIS; SALIVA LEVEL; VALIDATION PROCESS;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 1; HISTATINS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEOME; PROTEOMICS; SALIVA; SALIVARY PROLINE-RICH PROTEINS; SALIVARY PROTEINS AND PEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84867018735     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.714647     Document Type: Review

References (50)

1. Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J Dent Res 2007;86:680-693.
2. Amado F, Lobo MJ, Domingues P, Duarte JA, Vitorino R. Salivary peptidomics. Expert Rev Proteomics 2010;7:709-721.
3. Messana I, Inzitari R, Fanali C, Cabras T, Castagnola M. Facts and artifacts in proteomics of body fuids. What proteomics of saliva is telling us? J Sep Sci 2008;31:1948-1963.
4. Al-Tarawneh SK, Border MB, Dibble CF, Bencharit S. Defning salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS 2011;15:353-361.
5. Tipton JD, Tran JC, Catherman AD, Ahlf DR, Durbin KR, Kelleher NL. Analysis of intact protein isoforms by mass spectrometry. J Biol Chem 2011;286:25451-25458.
6. Inzitari R, Vento G, Capoluongo E, Boccacci S, Fanali C, Cabras T, Romagnoli C, et al. Proteomic analysis of salivary acidic proline-rich proteins in human preterm and at-term newborns. J Proteome Res 2007;6:1371-1377.
7. Cabras T, Pisano E, Boi R, Olianas A, Manconi B, Inzitari R, Fanali C, et al. Age-dependent modifcations of the human salivary secretory protein complex. J Proteome Res 2009;8:4126-4134.
8. Castagnola M, Inzitari R, Fanali C, Iavarone F, Vitali A, Desiderio C, Vento G, et al. The surprising composition of the salivary proteome of preterm human newborn. Mol Cell Proteomics 2011;10:M110.003467.
9. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Ofner GD, Troxler RF. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic efects on Candida albicans. J Biol Chem 1988;263:7472-7477.
10. Sabatini LM, Azen EA. Histatins, a family of salivary histidine-rich proteins, are encoded by at least two loci (HIS1 and HIS2). Biochem Biophys Res Commun 1989;160:495-502.
11. Castagnola M, Inzitari R, Rossetti DV, Olmi C, Cabras T, Piras V, Nicolussi P, et al. A cascade of 24 histatins (histatin 3 fragments) in human saliva. Suggestions for a pre-secretory sequential cleavage pathway. J Biol Chem 2004;279:41436-41443.
12. Cabras T, Fanali C, Monteiro JA, Amado F, Inzitari R, Desiderio C, Scarano E, et al. Tyrosine polysulfation of human salivary histatin 1. A post-translational modifcation specifc of the submandibular gland. J Proteome Res 2007;6:2472-2480.
13. Kaufman DL, Bennick A, Blum M, Keller PJ. Basic proline-rich proteins from human parotid saliva: relationships of the covalent structures of ten proteins from a single individual. Biochemistry 1991;30:3351-3356.
14. Isemura S, Saitoh E, Sanada K. Fractionation and characterization of basic proline-rich peptides of human parotid saliva and the amino acid sequence of proline-rich peptide P-E. J Biochem 1982;91:2067-2075.
15. Isemura S, Saitoh E, Sanada K. Further fractionation of basic proline-rich peptides from human parotid saliva and complete amino acid sequence of basic proline-rich peptide P-H. J Biochem 1983;94:1991-1999.
16. Messana I, Cabras T, Inzitari R, Lupi A, Zuppi C, Olmi C, Fadda MB, et al. Characterization of the human salivary basic proline-rich protein complex by a proteomic approach. J Proteome Res 2004;3:792-800.
17. Azen EA, Latreille P, Niece RL. PRBI gene variants coding for length and null polymorphisms among human salivary Ps, PmF, PmS, and Pe proline-rich proteins (PRPs). Am J Hum Genet 1993;53:264-278.
18. Azen EA, Amberger E, Fisher S, Prakobphol A, Niece RL. PRB1, PRB2, and PRB4 coded polymorphisms among human salivary concanavalin-A binding, II-1, and Po proline-rich proteins. Am J Hum Genet 1996;58:143-153.
19. Cabras T, Boi R, Pisano E, Iavarone F, Fanali C, Nemolato S, Faa G, et al. HPLC-ESI-MS and MS/MS structural characterization of multifucosylated N-glycoforms of the basic proline-rich protein IB-8a CON1+ in human saliva. J Sep Sci 2012;35:1079-1086.
20. Inzitari R, Cabras T, Onnis G, Olmi C, Mastinu A, Sanna MT, Pellegrini MG, et al. Diferent isoforms and post-translational modifcations of human salivary acidic proline-rich proteins. Proteomics 2005;5:805-815.
21. Schlesinger DH, Hay DI. Complete covalent structure of statherin, a tyrosine-rich acidic peptide which inhibits calcium phosphate precipitation from human parotid saliva. J Biol Chem 1977;252:1689-1695.
22. Schwartz SS, Hay DI, Schluckebier SK. Inhibition of calcium phosphate precipitation by human salivary statherin: structure-activity relationships. Calcif Tissue Int 1992;50:511-517.
23. Sabatini LM, Carlock LR, Johnson GW, Azen EA. cDNA cloning and chromosomal localization (4q11-13) of a gene for statherin, a regulator of calcium in saliva. Am J Hum Genet 1987;41:1048-1060.
24. Inzitari R, Cabras T, Rossetti DV, Fanali C, Vitali A, Pellegrini M, Paludetti G, et al. Detection in human saliva of diferent statherin and P-B fragments and derivatives. Proteomics 2006;6:6370-6379.
25. Cabras T, Inzitari R, Fanali C, Scarano E, Patamia M, Sanna MT, Pisano E, et al. HPLC-MS characterization of cyclo-statherin Q-37, a specifc cyclization product of human salivary statherin generated by transglutaminase 2. J Sep Sci 2006;29:2600-2608.
26. Messana I, Cabras T, Pisano E, Sanna MT, Olianas A, Manconi B, Pellegrini M, et al. Trafcking and postsecretory events responsible for the formation of secreted human salivary peptides: a proteomics approach. Mol Cell Proteomics 2008;7:911-926.
27. Lupi A, Messana I, Denotti G, Schininà ME, Gambarini G, Fadda MB, Vitali A, et al. Identifcation of the human salivary cystatin complex by the coupling of high-performance liquid chromatography and ion-trap mass spectrometry. Proteomics 2003;3:461-467.
28. Cabras T, Manconi B, Iavarone F, Fanali C, Nemolato S, Fiorita A, Scarano E, et al. RP-HPLC-ESI-MS evidenced that salivary cystatin B is detectable in adult human whole saliva mostly as S-modifed derivatives: S-Glutathionyl, S-cysteinyl and S-S 2-mer. J Proteomics 2012;75:908-913.
29. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol 1994;6:584-589.
30. Hannappel E. β-Tymosins. Ann N Y Acad Sci 2007;1112:21-37.
31. Pisano E, Cabras T, Montaldo C, Piras V, Inzitari R, Olmi C, Castagnola M, Messana I. Peptides of human gingival crevicular fuid determined by HPLC-ESI-MS. Eur J Oral Sci 2005;113:462-468.
32. Inzitari R, Cabras T, Pisano E, Fanali C, Manconi B, Scarano E, Fiorita A, et al. HPLC-ESI-MS analysis of oral human fuids reveals that gingival crevicular fuid is the main source of oral thymosins β(4) and β(10). J Sep Sci 2009;32:57-63.
33. Manconi B, Cabras T, Pisano E, Nemolato S, Inzitari R, Iavarone F, Fanali C, et al. Characterization of two isoforms of human SPRR3 from saliva of preterm human newborn and autoptic fetal oral mucosa, parotid and submandibular gland samples. Biochem Biophys Res Commun 2010;398:477-481.
34. Huq NL, Cross KJ, Ung M, Myroforidis H, Veith PD, Chen D, Stanton D, et al. A review of the salivary proteome and peptidome and saliva-derived therapeutics. Int J Pept Res Ter 2007;13:547-564.
35. Helmerhorst EJ, Sun X, Salih E, Oppenheim FG. Identifcation of Lys-Pro-Gln as a novel cleavage site specifcity of saliva-associated proteases. J Biol Chem 2008;283:19957-19966.
36. Vitorino R, Calheiros-Lobo MJ, Williams J, Ferrer-Correia AJ, Tomer KB, Duarte JA, Domingues PM, Amado FM. Peptidomic analysis of human acquired enamel pellicle. Biomed Chromatogr 2007;21:1107-1117.
37. Tibaldi E, Arrigoni G, Brunati AM, James P, Pinna LA. Analysis of a sub-proteome which co-purifes with and is phosphorylated by the Golgi casein kinase. Cell Mol Life Sci 2006;63:378-389.
38. Lominadze G, Rane MJ, Merchant M, Cai J, Ward RA, McLeish KR. Myeloid-related protein-14 is a p38 MAPK substrate in human neutrophils. J Immunol 2005;174:7257-7267.
39. Arnesen T, Van Damme P, Polevoda B, Helsens K, Evjenth R, Colaert N, Varhaug JE, et al. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Proc Natl Acad Sci USA 2009;106:8157-8162.
40. Nemolato S, Messana I, Cabras T, Manconi B, Inzitari R, Fanali C, Vento G, et al. Tymosin β(4) and β(10) levels in pre-term newborn oral cavity and foetal salivary glands evidence a switch of secretion during foetal development. PLoS ONE 2009;4:e5109.
41. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
42. Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol 2008;128:2365-2380.
43. Nemolato S, Restivo A, Cabras T, Coni P, Zorcolo L, Orrù G, Fanari M, et al. Tymosin β 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition. Cancer Biol Ter 2012;13:191-197.
44. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008;14:818-829.
45. Cabras T, Melis M, Castagnola M, Padiglia A, Tepper BJ, Messana I, Tomassini Barbarossa I. Responsiveness to 6-n-propylthiouracil (PROP) is associated with salivary levels of two specifc basic proline-rich proteins in humans. PLoS ONE 2012;7:e30962.
46. Castagnola M, Messana I, Inzitari R, Fanali C, Cabras T, Morelli A, Pecoraro AM, et al. Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J Proteome Res 2008;7:5327-5332.
47. Cabras T, Pisano E, Mastinu A, Denotti G, Pusceddu P P, Inzitari R, Fanali C, et al. Alterations of the salivary secretory peptidome profle in children afected by type 1 diabetes. Mol Cell Proteomics 2010;9:2099-2108.
48. Peluso G, De Santis M, Inzitari R, Fanali C, Cabras T, Messana I, Castagnola M, Ferraccioli GF. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and afer pilocarpine treatment. Arthritis Rheum 2007;56:2216-2222.
49. Rigante D, Inzitari R, Carone M, Fanali C, Stabile A, Cabras T, Capoluongo E, et al. Correspondence between clinical improvement and proteomic changes of the salivary peptide complex in a child with primary Sjögren syndrome. Rheumatol Int 2008;28:801-806.
50. Fanali C, Inzitari R, Cabras T, Pisano E, Castagnola M, Celletti R, Manni A, Messana I. alpha-Defensin levels in whole saliva of totally edentulous subjects. Int J Immunopathol Pharmacol 2008;21: 845-849.